Sibel Health is an award-winning medical technology company focused on delivering better health data for all through advanced sensor development, novel data analytics, and cloud computing. Sibel is commercializing ANNE One - the world's first ICU-grade wearable monitoring platform for all ages - which has now been deployed worldwide in partnership with large medical technology, philanthropic, pharmaceutical, and insurer partners.
Steve Xu MD, MSc is a physician-engineer, board-certified dermatologist, and innovator. He is currently the CEO of Sibel Health, Medical Director of the Querrey Simpson Institute for Bioelectronics at Northwestern University, and Assistant Professor in the Departments of Biomedical Engineering, Dermatology and Pediatrics at Northwestern University. Dr. Xu has authored more than 100 peer-reviewed publications and listed as an inventor on 13 pending and granted patents in the area of digital medicine. His publications have appeared in The New England Journal of Medicine, Science, Nature, and the Proceedings of the National Academies of Sciences garnering press attention from sources such as The New York Times, CNN, The Washington Post, and the BBC. As part of his collaborative research efforts, several of his inventions have been licensed to early stage companies commercializing the core technology. He received his undergraduate degree in bioengineering from Rice University summa cum laude. He completed his medical training at Harvard Medical School with special honors as a Soros Fellow, and a Masters in Health Policy and Finance with Merit from The London School of Economics as a Marshall Scholar. Finally, he completed an NIH-funded post-doctoral fellowship in Northwestern’s Department of Materials Science and Engineering under Professor John Rogers.